Naik, Jaesh http://orcid.org/0000-0002-6581-350X
Beavers, Norma
Nilsson, Fredrik O. L. http://orcid.org/0000-0002-1905-4047
Iadeluca, Laura http://orcid.org/0000-0002-2379-6094
Lowry, Chrissy
Funding for this research was provided by:
Pfizer
Article History
Accepted: 26 March 2023
First Online: 12 May 2023
Declarations
:
: This study was sponsored by Pfizer Inc.
: Fredrik O.L. Nilsson is an employee of Pfizer AB, Sweden, and owns stock in Pfizer Inc. At the time this study was conducted, Laura Iadeluca was an employee of Pfizer Inc, and owns stock in Pfizer Inc. Chrissy Lowry and Norma Beavers are employees of Lumanity, which was a paid consultant to Pfizer in connection with the development of this manuscript. At the time this study was conducted, Jaesh Naik was an employee of Lumanity, which was a paid consultant to Pfizer in connection with the development of this manuscript. The authors did not receive direct payment as a result of this work outside of their normal salary payments.
: Data are contained within the article and its electronic supplementary material.
: Not applicable.
: Not applicable.
: Not applicable.
: Available upon request.
: This manuscript was written and edited by Jaesh Naik, Norma Beavers, Fredrik O.L. Nilsson, Laura Iadeluca and Chrissy Lowry. The global cost-effectiveness model was developed by Jaesh Naik and Matthew Massello. Figures and tables were designed by Jaesh Naik and Chrissy Lowry. All authors approved the final version of the manuscript.